Skip to content

Author

R. Ghalehtaki

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

The Efficacy of Immune-checkpoint Inhibitors in Combination with Definitive Chemoradiotherapy in Non-metastatic Esophageal SCC: A Systematic Review and Meta-analysis.

BACKGROUND Inoperable esophageal squamous cell carcinoma (ESCC) remains a challenging malignancy. Immune checkpoint inhibitors (ICIs) have shown activity in esophageal cancer. This systematic review evaluated the efficacy and safety of adding immune checkpoint inhibitors to definitive chemoradiotherapy (dCRT) in this s...

R. Ghalehtaki, Alireza Shariati, Z. Moradi et al. · 0 citations
Sep 2026

Treatment Outcomes in Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy Versus 3D-Conformal Radiotherapy Techniques: A Single-Center Experience in a Developing Country.

BACKGROUND Radiotherapy (RT) is the primary treatment for non-metastatic nasopharyngeal cancer (NPC). While intensity-modulated RT (IMRT) is preferred in wealthy regions, three-dimensional conformal RT (3D-CRT) remains common in resource-limited settings. This study evaluated IMRT versus 3D-CRT for NPC, focusing on sur...

Pooria Mousavi, A. Kazemian, Ehsan Saraee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.